Skip to main content

Table 2 Presence of HBsAg according to potential exposure

From: Hepatitis B infection and risk factors among children living with HIV in Yaounde, Cameroon: an integrated management

Exposure   N Positivity rate of HBsAg p- value
Preterm baby Yes 5 0 p = 0.25
X2 = 1.3
No 78 2 (2.6%)
Feeding option Exclusive breastfeeding 24 2 (8.3%) p = 0.41
X2 = 1.76
Replacement feeding 18 00
Mixed feeding 41 00
Antiseptic bath at birth Yes 21 00 p = 1
X2 = 00
No 62 2 (3.2%)
Infant anti-HBV vaccination status Yes 50 00 p = 0.3
X2 = 1.063
No 33 02 (6.1%)
Maternal HBV status during pregnancy Negative 08 00 p = 0.0097
X2 = 11.374
Positive 01 00
Unknown 69 02 (2.9%)
Vaccinated 05 00
Delivery mode Normal vaginal 82 02 (2.4%) p = 0.0018
X2 = 9.75
Caesarean section 01 00
Gravidity Primiparous 19 00 p = 0.94
X2 = 0.005
Multiparous 64 02 (3.1%)
Maternal HAART during pregnancy TENLAM-E 64 1 (1.5%) p = 0.48
X2 = 2.459
Other regimens 13 1 (7.7%)
None 6 0
  1. HAART Highly Active Antiretroviral Therapy, TENLAM-E tenofovir-lamivudine-efavirenz, HBV hepatitis B virus; In bold are significant HBV prevalence